Latest Rosacea Review Newsletter Now Available Online

Posted: 08/23/2016

The latest Rosacea Review newsletter is now available online. This issue includes a report on comorbidity studies that potentially link rosacea to Alzheimer’s and Parkinson’s diseases, as well as an interview with medical scientists at John Hopkins School of Medicine on the recent trend toward research on rosacea comorbidities. 

In other research news, two recent studies on ocular rosacea yielded new findings that help in understanding the disease’s eye symptoms. In an effort to learn even more about ocular rosacea, the issue also includes a survey asking rosacea patients about their experiences with eye symptoms. Take the survey here, and watch for the results in a future issue of Rosacea Review.

The newsletter also includes tips for minimizing the unpredictable and disruptive flare-ups of rosacea, and the results of a survey on medications rosacea patients typically use.

Consider joining the NRS, or renewing your NRS membership today! To help win the fight against rosacea, renew or begin your membership here. Your donation will support the Society’s important medical research grants program.

Social Media Editor: Emma Terhaar

Contact Us

Phone:
1-888-NO-BLUSH
Email:
rosaceas@aol.com
National Rosacea Society
196 James St.
Barrington, IL 60010

Our Mission

The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace

consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.